c-erbB2 and topoisomerase IIα protein expression independently predict poor survival in primary human breast cancer: a retrospective study

Table 3 Medical treatment for primary breast cancer in the study patients (N = 198)

Therapy type	Intervention	n (%)
Adjuvant hormone therapy	No hormone therapy	137 (69.2)
	Tamoxifen	61 (30.8)
Adjuvant chemotherapy	Anthracycline-containing regimens	46 (23.2)
	Anthracycline-free regimens	36 (18.2)
	No chemotherapy	116 (58.6)
	No adjuvant therapy	55 (27.8)

ISSN: 1465-542X